These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes. Taniguchi Y; Pippin JW; Hagmann H; Krofft RD; Chang AM; Zhang J; Terada Y; Brinkkoetter P; Shankland SJ Am J Physiol Renal Physiol; 2012 May; 302(9):F1161-71. PubMed ID: 22262481 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis. Zheng YL; Zhang X; Fu HX; Guo M; Shukla V; Amin ND; E J; Bao L; Luo HY; Li B; Lu XH; Gao YC PLoS One; 2016; 11(8):e0160252. PubMed ID: 27479491 [TBL] [Abstract][Full Text] [Related]
5. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway. Zhang Y; Li H; Hao J; Zhou Y; Liu W Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698 [TBL] [Abstract][Full Text] [Related]
6. Cyclin I and p35 determine the subcellular distribution of Cdk5. Hagmann H; Taniguchi Y; Pippin JW; Kauerz HM; Benzing T; Shankland SJ; Brinkkoetter PT Am J Physiol Cell Physiol; 2015 Feb; 308(4):C339-47. PubMed ID: 25500740 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. Fornoni A; Li H; Foschi A; Striker GE; Striker LJ Am J Pathol; 2001 Jan; 158(1):275-80. PubMed ID: 11141501 [TBL] [Abstract][Full Text] [Related]
8. The Atypical Cyclin-Dependent Kinase 5 (Cdk5) Guards Podocytes from Apoptosis in Glomerular Disease While Being Dispensable for Podocyte Development. Mangold N; Pippin J; Unnersjoe-Jess D; Koehler S; Shankland S; Brähler S; Schermer B; Benzing T; Brinkkoetter PT; Hagmann H Cells; 2021 Sep; 10(9):. PubMed ID: 34572114 [TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Wang CX; Song JH; Song DK; Yong VW; Shuaib A; Hao C Cell Death Differ; 2006 Jul; 13(7):1203-12. PubMed ID: 16273078 [TBL] [Abstract][Full Text] [Related]
10. p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo. Brinkkoetter PT; Wu JS; Ohse T; Krofft RD; Schermer B; Benzing T; Pippin JW; Shankland SJ Kidney Int; 2010 Apr; 77(8):690-9. PubMed ID: 20130526 [TBL] [Abstract][Full Text] [Related]
11. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside. Ma J; Matsusaka T; Yang HC; Zhong J; Takagi N; Fogo AB; Kon V; Ichikawa I Pediatr Res; 2011 Jul; 70(1):83-9. PubMed ID: 21451433 [TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology. Griffin SV; Hiromura K; Pippin J; Petermann AT; Blonski MJ; Krofft R; Takahashi S; Kulkarni AB; Shankland SJ Am J Pathol; 2004 Oct; 165(4):1175-85. PubMed ID: 15466384 [TBL] [Abstract][Full Text] [Related]
13. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain. Ramos-Miguel A; García-Sevilla JA Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847 [TBL] [Abstract][Full Text] [Related]
14. Nestin protects mouse podocytes against high glucose-induced apoptosis by a Cdk5-dependent mechanism. Liu W; Zhang Y; Hao J; Liu S; Liu Q; Zhao S; Shi Y; Duan H J Cell Biochem; 2012 Oct; 113(10):3186-96. PubMed ID: 22614921 [TBL] [Abstract][Full Text] [Related]
15. MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism. Pei XY; Dai Y; Tenorio S; Lu J; Harada H; Dent P; Grant S Blood; 2007 Sep; 110(6):2092-101. PubMed ID: 17540843 [TBL] [Abstract][Full Text] [Related]
17. Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinase. Mellor HR; Rouschop KM; Wigfield SM; Wouters BG; Harris AL Biochem Pharmacol; 2010 Jun; 79(11):1562-72. PubMed ID: 20100468 [TBL] [Abstract][Full Text] [Related]
18. Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways. Hahn M; Li W; Yu C; Rahmani M; Dent P; Grant S Mol Cancer Ther; 2005 Mar; 4(3):457-70. PubMed ID: 15767555 [TBL] [Abstract][Full Text] [Related]
19. Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Zheng YL; Li BS; Kanungo J; Kesavapany S; Amin N; Grant P; Pant HC Mol Biol Cell; 2007 Feb; 18(2):404-13. PubMed ID: 17108320 [TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis. Terrano DT; Upreti M; Chambers TC Mol Cell Biol; 2010 Feb; 30(3):640-56. PubMed ID: 19917720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]